Policy

Data from the recent AMGA 2024 Medical Group Operations and Finance Survey reveal medical groups continue to face challenges related to providing quality, cost-effective care in a constantly evolving health care environment.

Evidence is uncertain about effectiveness of screening in men.

Study finds traditional Medicare doing just as well at providing dental, vision and hearing services

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, discusses the Trump administration's likely approach to health care.

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, talks about how the Trump administration is more experienced this time around.

A policy scenario to lower nicotine in tobacco products was published during the first Trump administration. FDA may be poised to bring it back for more consideration.

$3.9 million grant intended to boost primary care and help rural areas in the state

New perspective calls for regulatory reforms to address the rising trend of physician strikes in the U.S. based on international examples.

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, advises primary care physicians on how to best navigate potential health care shifts under the Trump administration.

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, talks about significant long-term implications of the Trump administration's approach to health care policy.

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, explains how the Trump administration could work together, or clash, with Congress on health care legislation during their next term.

A Weill Cornell Medicine study found that one-third of all Medicare Part D pharmacy spending and nearly 40% of specialty drug spending within Medicare Part D was through pharmacies owned by the four largest PBMs: CVS, UnitedHealth Group, Cigna and Humana.

Financial sustainability of some hospitals comes into question

Steady monthly growth was even with 2023, according to latest figures from Bureau of Labor Statistics.

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, explains how the Trump administration might approach drug pricing policy.

Two companies highlighted in bipartisan review of ‘detrimental effects of PE ownership on hospitals and their patients.’

Opting out of Medicare might be your only choice

With time still left to enroll, the 2025 marketplace open enrollment period has seen 11.6 million more enrollees compared to 2021.

The health care industry must start addressing high costs, low accessibility, lack of personalization, and complexity that are keeping Americans from getting the care they need.

MGMA: Late 2024 legislation had some help for health care, but House, Senate need to act now.

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, discusses how reforms to insurance regulations could impact patients and primary care.

The Biden-Harris administration finalized a rule to remove medical debt from consumer credit reports and bar lenders from using medical information in lending decisions.

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, explains what changes could be made to Medicare and Medicaid under the Trump administration.

Rule would modify HIPAA and require most providers to comply with more complex and thorough security guidelines.

Where will you go to meet fellow professionals this year?

Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, discusses how she expects the Trump administration to approach the Affordable Care Act.

Sheila P. Burke, chair of Government Relations and Public Policy Group at Baker Donelson Law Firm, provides a forecast of the Trump administration's top health care priorities.

Recommendations and resources from U.S. Surgeon General Vivek Murthy, MD, MBA.

New advisory lists evidence and recommends more public awareness of increased cancer risk from beer, wine and spirits.

Less clear is whether social drivers of health screenings are improving patient outcomes, according to a new study.